Literature DB >> 15151942

Histopathological validation of the sentinel node concept in cervical cancer.

E Barranger1, A Cortez, F Commo, O Marpeau, S Uzan, E Darai, P Callard.   

Abstract

BACKGROUND: The sentinel node (SN) is defined as the first node in the lymphatic system that drains a tumor site. If the SN is not metastatic, then all other nodes should also be disease-free. We used serial sections and immunohistochemical (IHC) staining to examine both sentinel and non-sentinel nodes (non-SNs).
MATERIALS AND METHODS: From July 2001 to March 2003, 18 patients (median age, 48 years) with cervical cancer (stage IA2, one patient; stage IB1, nine patients; stage IB2, three patients; stage IIA, three patients; and stage IIB, two patients) underwent a laparoscopic SN procedure based on a combined detection method, followed by complete laparoscopic pelvic lymphadenectomy. If the SN was free of metastasis by both hematoxylin and eosin (H&E) and IHC staining, all non-SNs were also examined by the combined staining method.
RESULTS: A mean of 2.4 SNs (range 1-5) and 8 non-SNs (range 4-14) were excised per patient. Eight SNs (18.2%) from five patients (27.8%) were found to be metastatic at the final histological assessment, including two macrometastatic SNs, three micrometastatic SNs and isolated tumor cells in three SNs. In 13 patients, no metastatic SN involvement was detected by H&E and IHC staining. In these 13 patients, 106 non-SNs were examined by serial sectioning and IHC, and none was found to be metastatic.
CONCLUSIONS: The SN procedure appears to reliably predict the metastatic status of the regional lymphatic basin in patients with cervical cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15151942     DOI: 10.1093/annonc/mdh227

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  7 in total

1.  Usefulness of sentinel lymph node detection in early stages of cervical cancer.

Authors:  I Roca; A P Caresia; A Gil-Moreno; P Pifarre; S Aguade-Bruix; J Castell-Conesa; J M Martínez-Palones; J Xercavins
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05-21       Impact factor: 9.236

Review 2.  [Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies].

Authors:  L-C Horn; J Einenkel; M Höckel; H Kölbl; F Kommoss; S F Lax; L Riethdorf; H-G Schnürch; D Schmidt
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

Review 3.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

4.  Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer.

Authors:  E Chéreau; J-G Feron; M Ballester; C Coutant; C Bezu; R Rouzier; E Touboul; E Daraï
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

5.  Potential risks in sentinel lymph node biopsy for cervical cancer: a single-institution pilot study.

Authors:  Hua Tu; Ting Wan; Xinke Zhang; Haifeng Gu; Yanling Feng; He Huang; Jihong Liu
Journal:  World J Surg Oncol       Date:  2020-06-18       Impact factor: 2.754

Review 6.  Ultrastaging of lymph node in uterine cancers.

Authors:  Corinne Bézu; Charles Coutant; Marcos Ballester; Jean-Guillaume Feron; Roman Rouzier; Serge Uzan; Emile Daraï
Journal:  J Exp Clin Cancer Res       Date:  2010-01-21

Review 7.  The sentinel node in gynaecological malignancies.

Authors:  J Balega; P O Van Trappen
Journal:  Cancer Imaging       Date:  2006-02-28       Impact factor: 3.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.